Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.1
-98.98%
60%
—
-61.37%
60%
—
5 Years
Score4.1
Net Growth-98.98%
Net Trend60%
Net Income Consistency—
Rev Growth-61.37%
Rev Trend60%
Revenue Consistency—
Collplant Biotechnologies Ltd fundamental performance
Between 2020 and 2025, revenue declined from $ 6M to $ 2M and net income went from -$ 5M to -$ 11M. Revenue increased in 3 of those 5 years; net income in 3.
Collplant Biotechnologies Ltd currently holds a 5-year HDB Score of 4.1 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.32 | — |
1 Year2025-08-12 | $ 3.15 | -89.86% |
5 Years2021-08-12 | $ 18.95 | -98.32% |
10 Years2016-06-08 | $ 17.89 | -98.22% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-06-08 |
|---|---|---|---|---|
| Price | $ 0.32 | $ 3.15 | $ 18.95 | $ 17.89 |
| Return | — | -89.86% | -98.32% | -98.22% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 2M | -$ 11M | $ 5M |
| 2024 | $ 515K | -$ 16M | $ 11M |
| 2023 | $ 10M | -$ 7M | $ 26M |
| 2022 | $ 299K | -$ 16M | $ 29M |
| 2021 | $ 15M | $ 237K | $ 43M |
| 2020 | $ 6M | -$ 5M | $ 3M |
| 2019 | $ 2M | -$ 11M | $ 3M |
| IPO2018 | $ 4M | -$ 6M | $ 5M |
Explore beyond CLGN
You're looking at Collplant Biotechnologies Ltd. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
